Skip to main content
VCbacked
Log inGet Started

Avisi Technologies

Redwood City, United States

Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.

$6.3M raised
Oct 2023
Seed
Health CareMedical DeviceNanotechnology

Top Investors

National Science FoundationGaingelsGood Growth CapitalBen Franklin Technology Partners of Southeastern PennsylvaniaUniversity of Pennsylvania

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avisi Technologies

How much funding has Avisi Technologies raised?
Avisi Technologies has raised $6.3M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Who are Avisi Technologies's investors?
Avisi Technologies's investors include National Science Foundation, Gaingels, Good Growth Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, University of Pennsylvania.
Where is Avisi Technologies headquartered?
Avisi Technologies is headquartered in Redwood City, United States.
What does Avisi Technologies do?
Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
What stage is Avisi Technologies at?
Avisi Technologies is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Avisi Technologies — Funding & Investors." VCBacked, October 1, 2023, https://www.vcbacked.co/company/avisi-technologies. Accessed June 17, 2026.
APA
VCBacked. (2023). Avisi Technologies — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/avisi-technologies
Wikipedia (cite web)
{{cite web |title=Avisi Technologies — Funding & Investors |url=https://www.vcbacked.co/company/avisi-technologies |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K